Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News Levitee Labs Inc C.LVT

Alternate Symbol(s):  LVTTF

Levitee Labs Inc. is a Canada-based integrative wellness company. The Company focuses on the centralization of integrative wellness assets. It is involved in transforming the traditional landscape of mental health, addiction, and pain management treatments through evidence-based complementary medicines and psychedelic therapies through its portfolio of wellness assets. The Company’s portfolio... see more

Recent & Breaking News (CSE:LVT)

CSE Bulletin: Suspensions (BLMH, EGFV, GHG, GHG.WT, GPK, LVT, PPK)

Newsfile February 6, 2023

IIROC Trading Halt - LVT

Canada NewsWire February 6, 2023

Levitee Labs Announces Philip Van Den Berg to Join as Interim CEO and the Board of Directors and Close First Tranche of Private Placement for $1.5 Million

GlobeNewswire February 1, 2022

Today’s market summary: inflation reaches three-decade high

Trevor Abes  January 19, 2022

Levitee Labs (CSE:LVT) announces $3M private placement

John Ballem  January 19, 2022

Levitee Labs Announces Non-Brokered Private Placement of up to $3,000,000

GlobeNewswire January 18, 2022

Levitee Labs (CSE:LVT) signs distribution agreement with Body Energy Club

John Ballem  January 12, 2022

Levitee Labs Signs Retail Distribution Agreement with Body Energy Club for MONKE Nutraceuticals

GlobeNewswire January 12, 2022

Levitee Labs (CSE:LVT) partners with Canntab Therapeutics (CSE:PILL)

Trevor Abes  January 10, 2022

Levitee Labs Partners with Canntab Therapeutics to Provide Alternatives to Opioids

GlobeNewswire January 10, 2022

CORRECTION - Levitee Labs Announces Medical Advisory Board

GlobeNewswire January 6, 2022

Levitee Labs (CSE:LVT) forms a Medical Advisory Board

Brieanna McCutcheon  January 6, 2022

Levitee Labs Announces Medical Advisory Board

GlobeNewswire January 6, 2022

Levitee Labs Announces Strategic Partnership with LiveRx Research Group to Provide Equitable Access to Hepatitis C Care throughout Alberta, Canada

GlobeNewswire December 20, 2021

Stocks2Watch's Virtual Investor Luncheon Agenda Updated for Tuesday November 30

Newsfile November 25, 2021

Levitee Labs Appoints Noha ElSayed as Executive Director for Levitee Clinics and Levitee Pharmacies in the Alberta Region

GlobeNewswire November 15, 2021

Levitee Labs (CSE:LVT) to acquire specialty addiction pharmacies in B.C.

Trevor Abes  November 10, 2021

Levitee Labs Signs Letter of Intent to Acquire a Chain of Specialty Addiction Pharmacies Located in British Columbia

GlobeNewswire November 10, 2021

Levitee Labs Publishes First Combined Revenue Figures for September 2021 and October 2021

GlobeNewswire November 8, 2021

Levitee Labs Signs LOI to Acquire Controlling Interest in a R&D Compounding Pharmacy; Focus to be on Levitee-Branded Products

GlobeNewswire November 8, 2021